Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 11, Issue 4, 1997, Pages 453-457

  Hachenberg, Thomas ^a   Möllhoff, Thomas ^a   Holst, Dietmar ^b   Hammel, Dieter ^b   Brüssel, Thomas ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cardiac surgery; Dobutamine; Enoximone; Extracorporeal circulation; Mitral valve regurgitation; Nitroglycerin; Pulmonary hypertension

Indexed keywords

DOBUTAMINE; ENOXIMONE; GLYCERYL TRINITRATE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; HEART OUTPUT; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG VEIN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VENOUS PRESSURE;

EID: 0031003358     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(97)90054-9     Document Type: Article

References (34)

1. Ross J Jr: Afterload mismatch in aortic and mitral valve disease: Implications for surgical therapy. J Am Coll Cardiol 5:811-826, 1985
2. Hammermeister KE, Burchfiel C, Johnson R, et al: Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation 82: 380-389, 1990 (suppl IV)
3. Scott WC, Miller DC, Haverich A, et al: Operative risk of mitral valve replacement: Discriminant analysis of 1329 procedures. Circulation 72: 108-119, 1985 (suppl II)
4. Jackson JM, Thomas ST: Valvular heart disease, in Kaplan JA (ed): Cardiac Anesthesia (ed 3). Philadelphia, PA, Saunders, 1993, pp 629-680
5. Schwenzer KJ, Miller ED Jr: Hemodynamic effects of dobutamine in patients following mitral valve replacement. Anesth Analg 68:467-472, 1989
6. Lejeune P, Leeman M, Deloof T, et al: Pulmonary hemodynamic response to dopamine and dobutamine in hyperoxic and in hypoxic dogs. Anesthesiology 66:49-54, 1987
7. Sorkin EM, Brogden RN, Romankiewicz JA: Intravenous glyceryl trinitrate (nitroglycerin): A review of its pharmacological properties and therapeutic efficacy. Drugs 27:45-80, 1984
8. A/Q distribution early after cardiac surgery. Acta Anaesthesiol Scand 26:489-497, 1982
9. Alousi AA, Johnson DC: Pharmacology of the bipyridines: Amrinone and milrinone. Circulation 73: 10-24, 1986 (suppl III)
10. Vernon MW, Heel RC, Brogden RN: Enoximone: A review of its pharmacological properties and therapeutic potential. Drugs 42:997-1017, 1991
11. Bethke T, Eschenhagen T, Klimkiewicz A, et al: Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts. Drug Res 42:437-445, 1992
12. Dupuis JY, Bondy R, Cattran C, et al: Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: A comparison of their effects on hemodynamics and outcome. J Cardiothorac Vase Anesth 6:542-553, 1992
13. Lee HR, Hershberger RE, Port JD, et al: Low-dose enoximone in subjects awaiting cardiac transplantation: Clinical results and effects on beta-adrenergic receptors. J Thorac Cardiovasc Surg 102:246-258, 1991
14. Loisance D, Sailly JC: Cost-effectiveness in patients awaiting transplantation receiving intravenous inotropic support. Eur J Anaesthesiol 8: 9-13, 1993 (suppl)
15. Riley RL, Cournand A: "Ideal" alveolar air and the analysis of ventilation-perfusion relationships in the lungs. J Appl Physiol 1:825-847, 1949
16. Sachs L: Angewandte Statistik, Chap. 7. Berlin, Springer-Verlag, 1992
17. Smith NA, Kates RE, Lebsack C, et al: Clinical pharmacology of intravenous enoximone: Pharmacodynamics and pharmacokinetics in patients with heart failure. Am Heart J 122:755-763, 1991
18. Rutman HI, LeJemtel TH, Sonnenblick EH: Newer cardiotonic agents: Implications for patients with heart failure and ischemic heart disease. J Cardiothorac Anesth 1:59-70, 1987
19. Bailey JM, Levy JH, Rogers HG, et al: Pharmacokinetics of amrinone during cardiac surgery. Anesthesiology 75:961-968, 1991
20. Palevsky HI, Schloo BL, Pietra GG, et al: Primary pulmonary hypertension: Vascular structure, morphometry and responsiveness to vasodilator agents. Circulation 80:1207-1221, 1989
21. Leier CV, Binkley PF, Carpenter J, et al: Cardiovascular pharmacology of dopexamine in low output congestive heart failure. Am J Cardiol 62:94-99, 1988
22. Muikku O, Hynynen M, Salmenperä M, et al: Pulmonary vascular effects of trinitroglycerin and isosorbide dinitrate after cardiopulmonary bypass. Br J Anaesth 71:720-724, 1993
23. Möllhoff T, Rosiers P, van Aken H: Urapidil, sodium nitroprusside, and nitroglycerine: Effects of haemodynamics, venous admixture and arterial oxygenation after coronary artery bypass grafting. Drugs 40: 73-76, 1990(suppl 4)
24. Brodde OE, Zerkowski HR, Doetsch N, et al: Myocardial beta-adrenoceptor changes in heart failure: Concomitant reduction in beta-1 and beta-2 adrenoceptor function related to the degree of heart failure in patients with mitral valve diseases. J Am Coll Cardiol 14:323-331, 1989
25. Colucci WS, Wright RF, Jaski BE, et al: Milrinone and dobutamine in severe heart failure: Differing hemodynamic effects and individual patient responsiveness. Circulation 73: 175-183, 1986 (suppl III)
26. Butt AY, Dinh-Xuan AT, Pepke-Zaba J, et al: In vitro pulmonary vasorelaxant effect of the phosphodiesterase inhibitor enoximone. Angiology 44:289-294, 1993
27. McGregor M, Sniderman A: On pulmonary vascular resistance: The need for more precise definition. Am J Cardiol 55:217-221, 1985
28. Hughes JMB, Glazier JB, Rosenzwig DY, et al: Factors determining the distribution of pulmonary blood flow in patients with raised pulmonary pressure. Clin Sei 37:847-858, 1969
29. Agusti AGN, Rodriguez-Roisin R: Effect of pulmonary hypertension on gas exchange. Eur Respir 16:1371-1377, 1993
30. Hachenberg T, Tenling A, Nyström SO, et al: Ventilationperfusion inequality in patients undergoing cardiac surgery. Anesthesiology 80:509-519, 1994
31. Louagie Y, Gonzalez E, Jamart J, et al: Postcardiopulmonary bypass lung edema. Chest 103:86-95, 1993
32. Benumof JL, Wahrenbrock EA: Blunted hypoxic pulmonary vasoconstriction by increased lung vascular pressures. J Appl Physiol 38:846-850,1975
33. Tarr TJ, Moore NA, Frazer RS, et al: Haemodynamic effects and comparison of enoximone, dobutamine and dopamine following mitral valve surgery. Eur J Anaesthesiol 10:15-24, 1993
34. Hess W: The effects of amrinone on the right side of the heart. J Cardiothorac Anesth 3: 38-44, 1989 (suppl 2)